Retiring with $1 million in superannuation is a big goal, but these three tips could help Australians work towards it.

Search rankings still matter, but now so does becoming the trusted source AI platforms choose to cite and recommend, which is ...

Here are 5 important investment skills you must develop for successful long-term investing (typically10+ years or ...

If you’re going to be drinking alcohol in this heat, you may want to keep safety in mind. For many people, the Fourth of July weekend means fireworks, barbecues, and ...

Every company is talking about how AI will enhance efficiency. But here’s the question almost nobody is asking: Are you ...

The Food and Drug Administration on Monday published the names of eight new panelists who will serve on a committee advising ...

Wegovy (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist that mimics the effects of the gut hormone GLP-1, which is released after eating to help regulate appetite and calorie intake ...

FDA proposes excluding blockbuster weight-loss drugs from 503B compounding list Move could limit bulk production by outsourcing facilities Novo and Lilly support FDA stance If finalized, the move ...

The FDA has clarified its policies regarding GLP-1s, stating that pharmacies must stop compounding GLP-1 drugs once branded versions are removed from the agency’s shortage list, signaling a narrower ...

Weight-loss company Noom has acquired 503A pharmacy Tailor Made Compounding, which Noom said will allow it to expand its behavior change programs and move beyond weight health. Tailor Made provides ...

Drugmaker Eli Lilly says some copycat versions of its GLP-1 medications pose unique safety concerns — here’s what you need to know. A new study funded by Eli Lilly found that mixing compounded ...

Though it’s hard to say exactly what the future holds for mass GLP-1 compounding, the pressure is mounting from multiple angles in the U.S. as drugmakers and the FDA alike seek to crack down on the ...